AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations

[ad_1] Today, a brief rundown of news announced ahead of the J.P. Morgan Healthcare Conference, including licensing deals from AbbVie and Novartis, earnings announcements from Vertex Pharmaceuticals and Alnylam Pharmaceuticals, and a regulatory updates from Beam Therapeutics and Atara Biotherapeutics. AbbVie is paying Yantai, China-based RemeGen $650 million up front, and potentially more than $5…

Read More

Omidenepag isopropyl lowers IOP over 5 years

[ad_1] January 12, 2026 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . ” data-action=subscribe> Subscribe We were unable to process your request. Please try again later. If you continue to…

Read More

Jubilant Biosys Announces New Facility in India

[ad_1] On Jan. 12, 2026, Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, announced at the JP Morgan Healthcare Conference, which is being held in San Francisco from January 12–15, that it is opening a new discovery and preclinical facility at Noida in India (1). The new facility will double the contract…

Read More

8 Unexpected Additions for Better Digestion

[ad_1] Written By: Megan Barefoot It felt like a long 2025 and December was even longer and filled with it’s own challenges but it’s time to let it go and leave it beind. January is the month of fresh starts for a lot of things but when it comes to digestion, drastic cleanses and restrictive…

Read More